The potential of heme oxygenase-1 (HO-1) as a biomarker and therapeutic target is also to be considered, as elevated serum levels of HO-1 have been associated with better outcomes in patients with intracerebral hemorrhage [89]. Here, HMOX1 is linked to intracerebral hemorrhage.